These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 20541374)

  • 1. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
    Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease.
    Choo IH; Lee DY; Oh JS; Lee JS; Lee DS; Song IC; Youn JC; Kim SG; Kim KW; Jhoo JH; Woo JI
    Neurobiol Aging; 2010 May; 31(5):772-9. PubMed ID: 18687503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment.
    Thomann PA; Roth AS; Dos Santos V; Toro P; Essig M; Schröder J
    Dement Geriatr Cogn Disord; 2008; 26(4):300-5. PubMed ID: 18843182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.
    Teipel SJ; Ewers M; Wolf S; Jessen F; Kölsch H; Arlt S; Luckhaus C; Schönknecht P; Schmidtke K; Heuser I; Frölich L; Ende G; Pantel J; Wiltfang J; Rakebrandt F; Peters O; Born C; Kornhuber J; Hampel H
    Psychiatry Res; 2010 Jun; 182(3):244-50. PubMed ID: 20493672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
    Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H
    Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study.
    Babiloni C; Benussi L; Binetti G; Cassetta E; Dal Forno G; Del Percio C; Ferreri F; Ferri R; Frisoni G; Ghidoni R; Miniussi C; Rodriguez G; Romani GL; Squitti R; Ventriglia MC; Rossini PM
    Ann Neurol; 2006 Feb; 59(2):323-34. PubMed ID: 16358334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structural cerebral changes in subjects with mild cognitive impairment].
    Pantel J; Hüger DR; Kratz B; Minnemann E; Martin M; Schad LR; Essig M; Schröder J
    Nervenarzt; 2002 Sep; 73(9):845-50. PubMed ID: 12215875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease.
    Shiino A; Watanabe T; Maeda K; Kotani E; Akiguchi I; Matsuda M
    Neuroimage; 2006 Oct; 33(1):17-26. PubMed ID: 16904912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables.
    Luckhaus C; Jänner M; Cohnen M; Flüss MO; Teipel SJ; Grothe M; Hampel H; Kornhuber J; Rüther E; Peters O; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Eur J Neurol; 2010 Dec; 17(12):1437-44. PubMed ID: 20443979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies.
    Shi F; Liu B; Zhou Y; Yu C; Jiang T
    Hippocampus; 2009 Nov; 19(11):1055-64. PubMed ID: 19309039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.